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Abstract
We report a patient with a unique and complex cytogenetic abnormality involving mosaicism for a
small ring X and deleted Xp derivative chromosome with tandem duplication at the break point.
The patient presented with failure to thrive, muscular hypotonia, and minor facial anatomic
anomalies, all concerning for Turner syndrome. Brain MRI revealed mild thinning of the corpus
callosum, an apparent decrease in ventricular white matter volume, and an asymmetric myelination
pattern. Array comparative genome hybridization analysis revealed mosaicism for the X
chromosome, deletion of the short arm of an X chromosome, and a duplication of chromosome
region Xp11.21-p11.22. G-banded chromosome and FISH analyses revealed three abnormal cell
lines: 46,X,der(X)del(X)(p11.23)dup(X)(p11.21p11.22)/46,X,r(X)(q11.1q13.1)/45,X. The small ring
X chromosome was estimated to be 5.2 Mb in size and encompassed the centromere and Xq
pericentromeric region. X chromosome inactivation (XCI) studies demonstrated a skewed pattern
suggesting that the ring X remained active, likely contributing to the observed clinical features of
brain dysmyelination. We hypothesize that a prezygotic asymmetric crossing over within a loop
formed during meiosis in an X chromosome with a paracentric inversion resulted in an
intermediate dicentric chromosome. An uneven breakage of the dicentric chromosome in the early
postzygotic period might have resulted in the formation of one cell line with the X chromosome
carrying a terminal deletion and pericentromeric duplication of the short arm and the second cell
line with the X chromosome carrying a complete deletion of Xp. The cell line carrying the deletion
of Xp could have then stabilized through self-circularization and formation of the ring X
chromosome.
Background
Turner syndrome is diagnosed in 1 of 5,000 live female
births. Six to fifteen percent of patients with Turner syn-
drome are mosaic carriers of a ring X chromosome. [1,2].
Several studies in the last decade have made significant
contributions to our understanding of the clinical pheno-
type in patients with r(X) [2-7]. It has been demonstrated
that most individuals carrying an r(X) chromosome show
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somatic signs of Turner syndrome, including short stature,
peripheral edema, characteristic facial features, low poste-
rior hairline, ovarian dysgenesis, endocrine disorders, and
autoimmune conditions. At the same time, patients with
r(X) can be at a higher risk for other findings, including
mental retardation, learning difficulties, autistic spectrum
disorders, and structural brain abnormalities [4,8,9].
These additional features can be partially explained by the
status of X inactivation, size, origin, and replication tim-
ing of the ring, genes affected by copy number variations,
and the percent of mosaicism [3,6,8,10]. Dennis et al.
(2000) concluded that severe r(X) phenotype can be seen
in patients with active, large r(X) chromosomes lacking
the XIST locus. Possible submicroscopic duplications in
active ring X chromosomes can go undetected by chromo-
somal analysis and may encompass dosage sensitive
genes, leading to functional disomy or even trisomy, and
resulting in clinically relevant phenotypes as has been
demonstrated in autosomes [11]. Additionally, a ring
chromosome comprised of Y-chromosomal material
should be distinguished from that containing X-derived
material. Early detection of Y-derived ring chromosomes
is necessary since individuals with r(Y) and Turner syn-
drome are at risk to develop gonadoblastoma, immature
teratoma, and endodermal sinus carcinoma, conditions
preventable by prophylactic gonadectomy [12]. Special
attention has been given also to the possible association
between r(X) and Kabuki syndrome [5,13,14]. McGinniss
et al (1997) have hypothesized that overexpression of
dosage sensitive genes from an X chromosome lacking
XIST is responsible for some cases with Kabuki syndrome-
like features.
Several methods have been used to characterize ring X
chromosomes including fluorescence in situ hybridization
(FISH), cell replication studies, real time PCR of XIST
expression, and the AR locus methylation status. Array
comparative genomic hybridization (aCGH) is a novel,
clinically validated method that can be applied to study-
ing r(X) chromosomes. CGH microarrays have been used
for detection of clinically relevant chromosomal abnor-
malities in a variety of postnatal patient samples [15-19].
Array CGH adds significantly to our ability to characterize
the origin and size of a ring chromosome, to detect chro-
mosomal mosaicism, and to identify additional micro-
scopic deletions or duplications [20-23]. By providing
important information about the structural features of
ring chromosomes, array CGH also gives new insight into
our understanding of the mechanisms of ring formation.
We present a patient with clinical features of Turner syn-
drome and a complex X chromosome rearrangement,
which was detected by chromosomal microarray analysis,
and further characterized by G-banding chromosome
analysis and X chromosome inactivation studies.
Clinical Presentation
A 10-month-old girl (RX1) was referred to the genetics
consultation service for evaluation of failure to thrive,
muscular hypotonia, and delayed closure of the anterior
and posterior fontanels. She was born at 32 weeks gesta-
tion with normal growth parameters, when adjusted for
gestational age. Evaluation at 10 months of age revealed
delayed growth parameters. Her weight and length were 3
standard deviations (SD) below the mean, and head cir-
cumference was at the 95th centile. At age 13 months, she
had no signs of gross motor, fine motor and or speech
delays. Her physical exam was remarkable for mild dys-
morphic features, including downslanting palpebral fis-
sures, wide nasal bridge, broad forehead, and down-
turned corners of the mouth. The previous workup for
failure to thrive included a non-diagnostic comprehensive
metabolic panel, skeletal survey and CT brain imaging.
Echocardiogram and renal ultrasound were normal. At
age 2 2/12 years she developed seizures. Brain imaging
revealed mild thinning of the corpus callosum, a decrease
in ventricular white matter volume, punctate enhance-
ment in the right caudate head likely representing a vascu-
lar malformation, and an asymmetric myelination pattern
within the left superior temporal lobe, raising the possi-
bility of cortical dysplasia. Her other current medical
problems include short stature, recurrent otitis media and
adenoid hypertrophy. Clinical findings and their compar-
ison to other reports of r(X) are summarized in Table 1.
Results
Array CGH using BAC/PAC suggested mosaicism for the X
chromosome, which was confirmed by G-banding chro-
mosome analysis showing the presence of three abnormal
cell lines: 46,X,del(X)(p11.23)/46,X,r(X)/45,X (Figure
1A–C). In the first cell line, 46,X,del(X)(p11.23), a dele-
tion of the short arm of the X chromosome at band
Xp11.23 encompassed approximately 48 Mb (Figure 1D).
The breakpoint mapped between probes RP11-1325A17
and RP11-416B14 at band Xp11.23. In the second cell
line, 46,X,r(X), the ring X chromosome was estimated to
be 5.2 Mb in size and encompassed the pericentromeric
region on the long arm of chromosome X from cen(X) to
Xq13.1. In the third cell line, monosomy X was found in
a single cell. Monosomy X was confirmed by FISH in addi-
tional cells. In addition, Chromosome Microarray Analy-
sis (CMA) detected a significant gain in copy number of
material from Xp11.21-p11.22 detected by several clones,
including RP11-258C19, RP11-541G7 and RP11-465B24
(Figure 1D). FISH analysis using the RP11-541G7 probe
showed that the duplicated region was present in the peri-
centromeric region of the short arm of the chromosome
del(X)(p11.23) and not in the ring X chromosome (Figure
1E and 1F). The karyotype was revised as follows:
46,X,der(X)del(X)(p11.23)dup(X)(p11.21p11.22)[9]/
46,X,r(X)(q11.1q13.1)[8]/45,X[1].Molecular Cytogenetics 2008, 1:16 http://www.molecularcytogenetics.org/content/1/1/16
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High resolution 244 K oligonucleotide microarray con-
firmed the gain in copy number of a segment correspond-
ing to pericentric region Xp11.22-p11.21 (Figure 2A). The
duplication was determined to be 4.6 Mb in size.
The duplicated region had two segments with a bimodal
distribution of log2 ratios (Figure 2B) referred to as regions
1 and 2. The log2 ratio corresponding to chromosome
Xq11.1-q13.1 approximated closer to zero, suggesting a
location on the ring X chromosome. This finding was con-
firmed by FISH, which demonstrated the presence of an
Table 1: Comparison of the clinical findings between patient RX1 and previously reported patients with r(X).
Findings Case 45,X/46,X,r(X)2 Reference
RX1
Constitutional symptoms
Short stature/failure to thrive + 98% [6]
Special education/Developmental delay - 33–52% [3,6]
Kabuki syndrome - 13% [3,4]
Craniofacial features
High arched palate - 34% [3]
Microcephaly - 29% [3]
Micrognathia - R1 [8,30]
Thin upper lip - R [31]
ENT
Recurrent and chronic otitis media + 62% [3]
Eyes
Strabismus - R [6,8]
Neck
Neck webbing - 4% [3]
Low posterior hairline - 19% [3]
Cardiovascular
Bicuspid aortic valve - 15% [31]
Aortic valve disease - 5% [31]
Aortic coarctation - 4% [31]
Endocrine system
Hypothyroidism - 10%3 [32]
Skeletal system
Short metacarpal bones - 23% [3]
Postaxial polydactyly - R [8]
Genitourinary system
Ovarian dysgenesis/ovarian failure n/a 40% [3]
Skin
Hypomelanosis of Ito - 2–6% [3,6]
Syndactyly - 15% [6]
Lymphedema - 18% [6]
Hypertrichosis/hirsutism - R [13,33,34]
Autoimmune disorders -9 % [ 3 ]
Neurologic findings
Seizures + 10% [6]
1"NR" indicates the finding was not reported and "R" indicates the finding was reported, but the percentage of patients is not known; "n/a" indicates 
that the data is not available.
2The percentages were quoted or calculated from the provided references.
3Percent of patients with autoimmune thyroid disease.Molecular Cytogenetics 2008, 1:16 http://www.molecularcytogenetics.org/content/1/1/16
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Chromosome and CMA findings in patient RX1 Figure 1
Chromosome and CMA findings in patient RX1. A-C. Partial karyotype demonstrating three cell lines: 
46,X,del(X)(p11.23)/46,X,r(X)/45,X. D: A whole genome plot of the chromosomal microarray analysis showing a loss in copy 
number of clones between RP11-1325A17 and RP11-416B14 of the short arm of chromosome X (blue arrow) and a gain in 
copy number of clones (RP11-258C19, RP11-541G7 and RP11-465B24) corresponding to the Xp pericentromeric region (red 
arrow). The start and end of the X chromosome is highlighted by two red lines. E: Two probes RP11-541G7 (red signal) and 
RP11-52N6 (green signal) corresponding to the duplicated region on array CGH can be seen on the normal X chromosome 
with the r(X) chromosome lacking hybridization. The hybridization to the der(X) is not shown. F: A duplication of the 
Xp11.21-p11.22 region detected on the interphase cell using RP11-541G7 probe inferred to originate from the der(X).Molecular Cytogenetics 2008, 1:16 http://www.molecularcytogenetics.org/content/1/1/16
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Results of the 244 K oligonucleotide Agilent array in case RX1 Figure 2
Results of the 244 K oligonucleotide Agilent array in case RX1. A: A graph representation of the 244 K Agilent oligo-
nucleotide array for case RX1 demonstrates a gain in copy number of probes covering the pericentromeric region of chromo-
some band Xp11. B: The chromosome band Xp11 is enlarged and shows two segments of log2 values: area 1 and area 2. C: 
Red signal from RP11-383C12 corresponding to AR locus can be found on both the structurally normal X chromosome and 
ring X in the 46,X,r(X) cell line. D: An interphase demonstrating tandem duplication of RP11-258C19 and RP11-465B24 on the 
derivative X chromosome.Molecular Cytogenetics 2008, 1:16 http://www.molecularcytogenetics.org/content/1/1/16
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AR-specific signal on r(X) (Figure 2C). Twenty of 100 ana-
lyzed ring X chromosomes were found to be dicentric
(Figure 3B, green signal).
BAC clones RP11-258C19 (red) and RP11-465B24
(green), corresponding to regions 1 and 2 (Figure 2B),
respectively, were used to demonstrate the "red-green-red-
green-green" signal pattern in interphase cells (Figure
2D), indicating the direct orientation of the duplication.
The metaphase images did not provide sufficient resolu-
tion to define the orientation of the tandem duplication
relative to the telomere (data not shown). The presence of
three green signals (probe RP11-465B24) and two red sig-
nals (probe RP11-258C19) on one of the X chromosomes
was in agreement with the 244 K array data, consistent
with the bimodal distribution of log2 ratios in regions 1
and 2 (Figure 2B).
FISH analysis with a XIST-specific probe showed the pres-
ence of two signals in cell line 46,X,der(X) (Figure 3A),
one XIST signal in cell lines 46,X,r(X) (Figure 3B) and
45,X, indicating that XIST is not present on the r(X) (Fig-
ure 3C). X inactivation (XCI) analysis revealed a 100%
skewing of the AR gene: two AR alleles prior to digestion
with HpaII (Figure 3D) and only one AR allele after diges-
tion with methylation-sensitive restriction enzyme HpaII
(Figure 3E). This suggested that the only cell line that has
an inactive X chromosome is the cell line with the der(X)
and it was preferentially inactivated and that the r(X)
chromosome was presumably active.
G-banding chromosome analysis of the mother revealed
no abnormalities. An additional maternal blood sample
to perform FISH using probes specific to Xp11.2 was not
available. A paternal sample was not available for analy-
sis.
XIST FISH and results of the X chromosome inactivation assay Figure 3
XIST FISH and results of the X chromosome inactivation assay. A-C: FISH analysis using a XIST probe (red signal) 
demonstrates the presence of two XIST loci in 46,X,der(X) and one XIST locus in cell lines 46,X,r(X) and 45,X. The green sig-
nal represents a centromere probe (Cen X). D: X chromosome inactivation study shows two AR alleles in the peripheral lym-
phocytes without HpaII digestion. E: XCI analysis shows only one AR allele after digestion with a methylation-sensitive 
restriction enzyme HpaII.Molecular Cytogenetics 2008, 1:16 http://www.molecularcytogenetics.org/content/1/1/16
Page 7 of 10
(page number not for citation purposes)
Discussion
This report presents the array CGH and cytogenetic find-
ings in a patient with Turner syndrome due to mosaic r(X)
and derivative chromosome with a deleted Xp segment
and a tandem duplication of bands Xp11.21-p11.22 at the
breakpoint. This combination has not been previously
reported. The patient's phenotype at the time of her most
recent evaluation at age 26 months included small stature,
delayed bone maturation, diffuse muscular hypotonia,
seizures, and mild developmental delay. Brain MRI
revealed mild thinning of the corpus callosum, an appar-
ent decrease in ventricular white matter volume, and an
asymmetric myelination pattern. Of note, there were no
features of Kabuki syndrome, a condition previously
reported in some patients with r(X) [5,13,14]. The most
plausible explanation for the brain imaging abnormalities
is the overexpression of dosage sensitive genes from the
ring X chromosome, which lacks XIST and thus presuma-
bly remains active. One of the genes present on the ring
chromosome, OPHN1, is known to participate in neuron
morphogenesis. When overexpressed in vitro, it can inter-
fere with the actin cytoskeleton, playing a crucial role in
axon growth and guidance, dendrite elaboration, and syn-
apse formation [24].
Array CGH studies detected and provided detailed charac-
terization of the copy number abnormality on chromo-
some X. The duplication of bands Xp11.21p-11.22, that
escaped detection by routine chromosome analysis, was
readily seen on the BAC-clone targeted chromosomal
microarray and the high resolution oligoarray analyses
(Figure 1D, Figure 2A and 2B). The array data was con-
firmed by FISH, which also localized the duplicated
region to the derivative chromosome, and not the r(X)
(Figure 3B).
The finding of a duplicated region associated with termi-
nal deletions in a ring chromosome has been described
previously [20,21]. Many of the reported cases had an
inverted duplication at the breakpoint. Rossi et al (2007)
identified two patients with concurrent deletion and
inverted contiguous duplication (inv dup del) in the ring
chromosomes and proposed that such abnormality could
be the result of recombination between homologous seg-
mental duplications located at the rearrangement's break-
points leading to an intermediate dicentric chromosome
followed by asymmetric breakage of the dicentric. Accord-
ing to this model, inv dup del undergoes an additional
step of self-circularization for stabilization of r(X).
Our case is different in two ways: (1) the duplication is
tandem and (2) the duplication is present in the non-cir-
cular chromosome in the presence of a ring chromosome.
The formation of tandem duplication at the terminal
breakpoint cannot be explained by concurrent deletion
and reunion at Xp, since it would have resulted in inverted
duplication, suggesting a different mechanism. Wolff et al
(1996) concluded that chromosome region Xp11.2 is
prone to breakage and reunion events between sister chro-
matids or homologous X chromosomes, and could be
responsible for the majority of i(Xq) monocentrics or
dicentrics. The pericentromeric region of Xp is particularly
rich in low copy repeats, thought to be responsible for six
classes of i(Xq) originating from breakpoints spanning
Xp11.21p11.22 [25].
The three cells lines in our patient may have resulted from
the instability of an intermediate dicentric chromosome
formed prezygotically. The presence of a complex tandem
duplication-triplication in Xp11.21p11.22 (Figure 2D)
led us to propose a model of der(X) and r(X) formation,
in which one of the parents may be a heterozygous carrier
for a clinically silent duplicated paracentric inversion of
chromosome band Xp11.1p11.22 (Figure 4). During the
pachytene phase of meiosis I, the inverted segment can
form a loop with a normal X chromosome (Figure 4A).
Asymmetric crossing over mediated by low copy repeats
within the loop may lead to the formation of a dicentric
chromosome with tandem duplication-triplication
between the centromeres (Figure 4B). In the early postzy-
gotic period, the dicentric chromosome could have under-
gone a breakage, wherein some of the cells retained a
chromosome with terminal deletion and pericentromeric
duplication of the short arm (Figure 4D), while other cells
retained a chromosome X with a complete deletion of the
short arm (Figure 4D). The cell line with del(Xp) could
have undergone stabilization through postzygotic termi-
nal deletion of the long arm with self-circularization and
formation of r(X) (Figure 4E). Finally, due to mitotic
instability, some of the abnormal X chromosomes were
lost resulting in third cell line 45,X. Unfortunately, paren-
tal chromosomes were not available for further analysis to
confirm this hypothesis.
Conclusion
The reported unique and complex cytogenetic abnormal-
ity involving mosaicism for r(X) and deleted Xp derivative
chromosome with tandem duplication at the break point
provides insight into the possible mechanism of der(X)
and r(X) formation. We suggest that XIST-mediated
silencing, size of r(X) and i(Xq), gene content and the
level of mosaicism all play important roles in determining
phenotypic outcomes. The parents of patients with r(X)
and derivative chromosomes with terminal duplications
should be offered evaluation using array CGH.
Materials and methods
Human Subjects
Following the initial result of the chromosomal microar-
ray analysis, an informed consent for the whole genomeMolecular Cytogenetics 2008, 1:16 http://www.molecularcytogenetics.org/content/1/1/16
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array-based oligonucleotide CGH study was obtained
from the mother. The research protocol was approved by
the Institutional Review Board (IRB) for Baylor College of
Medicine (BCM) and Affiliated Hospitals.
FISH Analysis
Chromosome and FISH analyses were performed on
peripheral blood lymphocytes using standard procedures.
Briefly, the BAC clone of interest was grown in TB media
with 20 μg/ml chloramphenicol. DNA was extracted from
bacterial artificial chromosome (BAC) clones (Eppendorf
Plasmid Mini Prep kit, Hamburg, Germany) and directly
labeled with SpectrumOrange™ dUTP by nick translation
(Vysis, Downer Grove, IL) according to the manufacturers'
instructions. Digital FISH images were captured by a
Power Macintosh G3 System and MacProbe version 4.4
(Applied Imaging; San Jose, CA).
Array-CGH analysis
The patient's DNA was extracted from whole blood using
the Puregene DNA extraction kit (Gentra, Minneapolis,
MN) according to the manufacturer's instructions and
studied by aCGH using the BAC/PAC microarray platform
(CMA V6.1) [26,27] and the 244 K whole genome oligo-
nucleotide microarray (Agilent, Santa Clara, CA). The
BAC/PAC microarray includes 1472 BAC and PAC clones,
covers ~150 genomic disorders with minimum backbone
coverage of every chromosome at the 650-band level of
cytogenetic resolution http://www.bcm.edu/geneticlabs/
cma/tables.html. The procedures for probe labeling and
The proposed mechanism of r(X) and i(Xq) formation Figure 4
The proposed mechanism of r(X) and i(Xq) formation. A: During the pachytene phase of meiosis I, a clinically silent 
inverted and duplicated segment X p11.1-p11.22 (green arrow) can form a loop with a normal X chromosome. Asymmetric 
crossing over within the loop may lead to the formation of dicentric chromosome with tandem duplication between the cen-
tromeres. B: After the zygote is formed, the dicentric chromosome could undergo fission with the formation of two cell lines. 
C: The cell retaining chromosome with terminal deletion and pericentromeric duplication of the short arm results in cell line 
46,X,der(X)del(X)(p11.23)dup(X)(p11.21p11.22). D: The other cell retaining chromosome X with a complete deletion of the 
short arm results in cell line 46,X,r(X)(q11.1q13.1). E: Mitotically unstable del(Xp) could undergo stabilization through postzy-
gotic terminal deletion of the long arm with self-circularization resulting in cell line r(X).Molecular Cytogenetics 2008, 1:16 http://www.molecularcytogenetics.org/content/1/1/16
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hybridization of our BAC arrays were reported previously
[26,27]. For the oligonucleotide microarray study, DNA
was digested, labeled, and hybridized according to the
manufacturer's instructions, with some modifications
[28]. The slides were scanned into image files using a
GenePix Model 4000B microarray scanner (Molecular
Devices, Sunnyvale, CA) or an Agilent G2565 laser scan-
ner. Microarray image files of oligonucleotide microarrays
were quantified using Agilent Feature extraction software
(v9.0), and text file outputs from the quantification anal-
ysis were imported either into the Agilent CGH Analytics
software program or converted to BAC-level emulation
data by combining oligo data corresponding to regions
encompassed by BAC clones ("emulated BAC clone") and
then using custom-written analysis software package for
copy number analysis, as described previously [16,27].
X chromosome inactivation (XCI)
X-inactivation studies were performed according to a pre-
viously described protocol with some modifications [29].
Briefly, two sets of reactions were set-up for each female,
including 100 ng of genomic DNA digested with the
methylation-sensitive restriction enzyme HpaII (NewEng-
land Biolabs, Ipswich, MA); and another 100 ng DNA
incubated with 1× enzyme buffer only. PCR primers
flanking the androgen receptor (AR) CAG repeat region
were as follows: 5'-ACCAGGTAGCCTGTGGGGCCTC-
TACGATGGGC-3' (forward) and 5'-CCAGAGCGT-
GCGCGAAGTGATCCAGAACCCGG-3' (reverse). PCR
amplification was performed using 0.5 ng from each DNA
sample. PCR products were analyzed using capillary elec-
trophoresis on the 3100 ABI Automated DNA Sequencer
with GeneMapper software. Random X chromosome
inactivation is expected to produce two signals if each
chromosome has a different AR allele and an intact XIST
locus. Non-random inactivation of an X chromosome or
the absence of an AR allele in a deleted chromosome will
result in PCR amplification of only one allele after diges-
tion with HpaII.
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